The Value of Neurospecific Protein S-100 and Lipoproteins in the Development of Multiple Sclerosis

This article describes the clinical picture of multiple sclerosis (MS) depending on indices of the neurospecificprotein s-100? and low-density lipoproteins. In patients with MS in the phase of activity, high levels ofs-100? protein and LDL were found. It means that in patients with MS, demyelination and degenerationprocess continues, and as a result, patients are more likely to develop new symptoms. Thus, the study resultsof s-100? protein and LDL can be used to predict possible development of adverse symptoms in multiplesclerosis.

Перевод пока недоступен